An early Moderna investor, Platinum Asset Management’s Bianca Ogden is leveraging fresh medical breakthroughs to ride a ...

A new therapy has the potential to cure hundreds of diseases — and even reverse aging. Credit...Photo illustration by Kensuke ...

Readout to Include One-Year Cohort 1 Results and Early Cohort 2 Data; Webcast Conference Call Planned to Review RIDGE-1 Data at ASGCT Additional ...

Apr 27, 2026--Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that th ...

Is VIR a good stock to buy? We came across a bullish thesis on Vir Biotechnology, Inc. on BioEquity Watch’s Substack. In this ...

While life sciences employment was down 0.3% nationally in 2024, it rose 1.9% in Washington, according to a new Life Science ...

The beauty AI space is evolving at a quick pace and billion-dollar businesses could soon be created and operated by a single ...

ZW191 demonstrates encouraging anti-tumor activity in heavily pretreated ovarian and endometrial cancers, regardless of FRα ...

Manufacturing Agreement Advances Metformin Ophthalmology Platform Toward First-in-Human Clinical Study Palm Beach Gardens, FL, April 15, 2026 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUB ...

Convergent Therapeutics Inc., a clinical-stage biotechnology company developing next-generation alpha-emitting radioantibodies for the treatment of advanced prostate cancer, today announced that ...

City’s largest biotech employer has cut more than 1,000 jobs in the last two years and is consolidating offices around the ...